Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Downgrades Kodiak Sciences to Sell, Announces $6 Price Target

Citigroup analyst Neena Bitritto-Garg downgrades Kodiak Sciences (NASDAQ:KOD) from Neutral to Sell and announces $6 price target.
byBenzinga Newsdesk
August 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Neena Bitritto-Garg downgrades Kodiak Sciences (NASDAQ:KOD) from Neutral to Sell and announces $6 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why ProMIS Neurosciences Stock Surged Today

By Ryan Gustafson
July 17, 2:22 PM
ProMIS Neurosciences Inc. (NASDAQ: PMN) shares skyrocketed Monday after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for Alzheimer's disease (AD), PMN310, and additional studies that further characterize a computationally-derived AD vaccine <

PMN